A California woman has filed a lawsuit against GlaxoSmithKline, alleging that her long-term use of Zantac caused her to develop breast cancer. According to the claim, she took brand-name Zantac and generic ranitidine products between 1997 and 2018. The lawsuit states that ranitidine exposed her to harmful levels of NDMA, a chemical linked to cancer, which she believes directly contributed to her diagnosis.

This case highlights growing concerns about the safety of Zantac and similar medications. While our firm is primarily focused on representing individuals with bladder and liver cancer claims in 2024, it’s essential for anyone affected by Zantac to understand their legal rights. If you’ve experienced health issues linked to Zantac, consult with a qualified attorney to explore your options.

By submitting your cell phone number, you agree to receive marketing messages from tortadvisor.com and its partners via voice calls, AI-generated calls, text messaging, or other automated methods. For details on how we use your information, please refer to our Privacy Policy.